Skip to main content

ADVERTISEMENT

Panelux trial

03/28/2019

Jerome Roncalli, MD, PhD1;  Matthieu Godin, MD2;  Kamel Boughalem, MD3;  John Shayne, MD4; Christophe Piot, MD, PhD5;  Bruno Huret, MD6;  Loic Belle, MD7;  Guillaume Cayla, MD, PhD8; Benjamin Faurie, MD9;  Max Amor, MD10;  Bernard Karsenty, MD11;  Florence Leclercq, MD, PhD12 

Jerome Roncalli, MD, PhD1;  Matthieu ...
Prolonged dual-antiplatelet therapy in high bleeding risk (HBR) patients undergoing percutaneous coronary intervention can be challenging. We assessed the clinical safety of bare-metal stent implantation followed by drug-coated balloon...
Prolonged dual-antiplatelet therapy in high bleeding risk (HBR) patients undergoing percutaneous coronary intervention can be challenging. We assessed the clinical safety of bare-metal stent implantation followed by drug-coated balloon...
Prolonged dual-antiplatelet...
03/28/2019
Journal of Invasive Cardiology